ABOUT SUMMIT’S CME WEBINARS:
- MDs, PAs, RNs
TWO Category 1 CME Credits
- LIVE Webinar
- Registration Fee: $35.00
- Panel discussion with LIVE Q & A following Presentations
- Physicians, Patients, Researchers, Students – Everyone is welcome!
- (Content subject to change)
Rudolph E. Tanzi, Ph.D.
Director, Genetics and Aging Research Unit, Massachusetts General Hospital East, Program in Neuroscience, Harvard Univ.
Dr. Rudolph Tanzi is the Director of the Genetics and Aging Research Unit, Co-Director of the McCance Center for Brain Health, Co-Director of the MassGeneral Insititute for Neurodegenerative Disease, and Vice-Chair of Neurology (Research), at Massachusetts General Hospital. He is also the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. Dr. Tanzi discovered several Alzheimer’s disease genes, including all three early-onset familial Alzheimer’s genes, and serves as director of the Alzheimer’s Genome Project, which identified the first innate immune AD gene, CD33. He is also developing therapies for treating and preventing AD using human brain organoid models of the disease. More recently, Dr. Tanzi introduced the “anti-microbial protection” hypothesis of AD implicating infection in the disease process. Dr. Tanzi has published roughly 600 papers, has received numerous awards including the Metropolitan Life Award, Potamkin Prize, Smithsonian American Ingenuity Award, and was on the 2015 TIME100 Most Influential People in the World list. Dr. Tanzi is a New York Times bestselling author, who has co-authored “Decoding Darkness” and three bestsellers with Deepak Chopra: “Super Brain”, “Super Genes”, and “The Healing Self”. He has hosted three Public Television shows, appears on various TV and internet news programs, and in his spare time, plays keyboards for Joe Perry, Aerosmith and other musicians.
“…over the past 25 years, I have directed the Alzheimer’s Genome Project. Most recently, we have also discovered a novel role for the amyloid beta protein, as an antimicrobial peptide that protects the brain against infection. In this hypothesis, plaques are seeded by microbes, e.g. herpes viruses, and serve to trap pathogenic microbes as part of the brain’s innate immune system. We are now searching for the exact microbes (bacterial, viral, fungal) that populate the AD brain and trigger amyloidosis as part of the “antimicrobial hypothesis of AD”…”
Jeanne F. Loring, Ph.D.
Board Director & Chief Science Officer,
Summit for Stem Cell Foundation
Jeanne F. Loring is the Professor Emeritus at the Scripps Research Institute where she was founding Director of the Center for Regenerative Medicine. She is also founder of two stem cell-based biotechnology companies, Arcos Bioscience (now part of Viacyte) and Aspen Neuroscience, a biotechnology company developing a neuron replacement therapy for Parkinson disease. Dr. Loring has more than 30 years of experience in both biotechnology and academic research, focusing on stem cells, genomics, embryology and neurobiology. She holds five patents on stem cells and genomics, and has published more than 100 research articles in scientific journals that have been cited in scientific publications more than 14,000 times. She serves on both scientific advisory and bioethics boards, and advises governmental and private granting agencies in several countries. Through her laboratory courses, she has trained more than 400 scientists in stem cell technology.
In addition to her work on Parkinson disease, Dr. Loring investigates multiple sclerosis and autism, and works with the San Diego Zoo Institute for Conservation Research in an effort to rescue the Northern white rhinoceros from extinction using stem cell technology. She is also involved in a project on the International Space Station to study neurogenerative disease.
Dr. Loring is an advocate for patients and an outspoken critic of stem cell clinics that operate outside of ethical or scientific oversight. She speaks out against unregulated stem cell therapies that have caused severe injuries and even death, and the clinics who convince desperately ill patients to pay for treatments that are not effective.
If you are unable to attend a LIVE webinar, you may cancel up to the scheduled time of the event and receive a full refund. No refunds or exchanges for On-Demand Recoded Webinars. (Not yet available.) Refunds or exchanges for a LIVE webinar will not be given for no shows. As an alternative to a refund, you can substitute a registration for a future live webinar or have your fee converted to a tax deductible donation.
You must contact [email protected]l.org to request a refund or move your registration to another webinar or to a donation. Cancelling your registration through GoToWebinar will NOT process a refund – you MUST contact Summit for Stem Cell Foundation at [email protected].
In the rare event that a webinar is cancelled or postponed due to unanticipated circumstances, registrants will be notified immediately and given the opportunity to either transfer their registration to another webinar or obtain a refund.
This policy supersedes all other policies regarding the LIVE CME Webinar series.